Public disclosures

SMITH PATRICK W

Company insiders · 10% owner · Insight Molecular Diagnostics Inc.

Advertisement
FollowLatest SEC filingSEC filer historyProfile details as reported on 2026-11-20.Following & alerts
Reported transaction lines
1
Buy lines
0
Sell lines
0

Filing activity by month

Original filing lines in up to 12 months with activity.

  • 2026-111

Frequently disclosed stocks

Disclosure history

More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSource
SMITH PATRICK W

10% owner · Insight Molecular Diagnostics Inc.

IMDX

Insight Molecular Diagnostics Inc.

Other transaction
Filing details

SEC transaction code J

Common Stock · Indirect ownership · See Footnote · Reported balance after transaction: 4401342 · Reflect shares of Insight Molecular Diagnostics Inc.'s (the "Issuer") common stock, no par value, purchased by the Reporting Person in an underwritten public offering of the Issuer at the public offering price of $1.75. · The shares of common stock reported herein are directly held by Patrick W Smith The Smith Irrevocable Trust U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust.

2026-11-172026-11-20

1,142,857 shares/units

SEC 4

Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.

Advertisement